LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX)

Q4 2020 13F Holders as of 31 Dec 2020

Type / Class
Equity / COMMON STOCK
Shares outstanding
363,214,619
Total 13F shares
122,029,255
Share change
+17,702,177
Total reported value
$417,334,864
Put/Call ratio
68%
Price per share
$3.42
Number of holders
100
Value change
+$65,690,726
Number of buys
52
Number of sells
42

Institutional Holders of LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) as of Q4 2020

As of 31 Dec 2020, LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) was held by 100 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 122,029,255 shares. The largest 10 holders included Artal Group S.A., BVF INC/IL, FMR LLC, Ulys, L.L.C., VANGUARD GROUP INC, BlackRock Inc., NEA Management Company, LLC, MORGAN STANLEY, PINNACLE ASSOCIATES LTD, and D. E. Shaw & Co., Inc.. This page lists 100 institutional shareholders reporting positions in this security for the Q4 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.